- Our Centres
- Centre for Burden of Disease and Cost-effectiveness
- ACE Prevention
Download the ACE Prevention final report [3MB]
ACE Prevention is a large, 5-year study that was funded by the National Health and Medical Research Council (NHMRC) and jointly led by Professor Theo Vos of the Centre for Burden of Disease and Cost-Effectiveness at the University of Queensland and Professor Rob Carter of the Deakin Health Economics Unit at Deakin University. The final report was presented on 8 September 2010.
The final report [3MB] provides a comprehensive overview of the findings of ACE Prevention. For results on specific topics, please see the listing below.
The specific objectives of ACE Prevention were to:
1. assess the relative cost-effectiveness of a comprehensive set of preventive interventions for non-communicable disease in Australia, together with a selected set of comparator care/cure interventions, as a critical input to resource allocation decisions in the health sector;
2. recommend a ‘menu’ of cost-effective interventions from which policy makers can choose an optimal mix of preventive interventions for non-communicable disease control within the constraints of current budgets allocated to prevention, and alternative scenarios of budgetary provision;
3. evaluate the impact on costs and outcomes separately for each of the interventions and combinations thereof if directed at Indigenous Australians; and
4. strengthen the use of evidence in health priority setting in by increasing the capacity among key stakeholders to more effectively incorporate research findings into policy and programme debates taking into account issues of equity, acceptability to stakeholders and feasibility of implementation.
To ensure maximum comparability between the results for different interventions, an ACE Prevention Economic Protocol [600kB] was developed.
|ACE Prevention section|